417 results on '"Martens, William"'
Search Results
2. The influence of genotype on the natural history of types 1 - 3 spinal muscular atrophy
3. Safety and efficacy of arimoclomol for inclusion body myositis: a multicentre, randomised, double-blind, placebo-controlled trial
4. Lean tissue mass measurements by dual-energy X-ray absorptiometry and associations with strength and functional outcome measures in facioscapulohumeral muscular dystrophy
5. A checklist for clinical trials in rare disease: obstacles and anticipatory actions-lessons learned from the FOR-DMD trial.
6. Health related quality of life in young, steroid-naïve boys with Duchenne muscular dystrophy
7. Developing standardized corticosteroid treatment for Duchenne muscular dystrophy.
8. Spatial Soundscape Superposition and Multimodal Interaction
9. Acquired amusia after a right middle cerebral artery infarction – a case study
10. Nusinersen Treatment in Adults with Spinal Muscular Atrophy
11. Reference curves of motor function outcomes in young steroid‐naïve males with Duchenne muscular dystrophy
12. Effects of vowel coloration on perceived directional offsets between single-syllable speech sounds
13. Safety and efficacy of arimoclomol for inclusion body myositis: a multicentre, randomised, double-blind, placebo-controlled trial
14. Identification training adapted to the learner’s vowel space aids in improving native Japanese speakers’ pronunciation of American English vowels
15. Comparison of independent, participant-led, high-resolution studies of pitch-matching in post-lingual single-sided cochlear implant recipients
16. Hearing aid processing affects acoustic features important for emotional responses to sounds
17. Mexiletine in Myotonic Dystrophy Type 1: A Randomized, Double-Blind, Placebo-Controlled Trial
18. Reference curves of motor function outcomes in young steroid‐naïve males with Duchenne muscular dystrophy.
19. Relationships between DMD mutations and neurodevelopment in dystrophinopathy
20. A longitudinal study of disease progression in facioscapulohumeral muscular dystrophy (FSHD).
21. The FSHD Composite Outcome Measure (FSHD-COM) is Reliable, Valid, and Measures Disease Progression (S7.005)
22. Motor Outcomes to Validate Evaluations in Facioscapulohumeral muscular dystrophy (MOVE FSHD): Preliminary Baseline Characteristics (S7.004)
23. Spatial Navigation by Seated Users of Multimodal Augmented Reality Systems
24. Applying adaptive recognition of the learner’s vowel space to English pronunciation training of native speakers of Japanese
25. Assessing Bulbar Function in Spinal Muscular Atrophy Using Patient-Reported Outcomes
26. Quantitative Evaluation of Lower Extremity Joint Contractures in Spinal Muscular Atrophy: Implications for Motor Function
27. Perception of Audio-Generated and Custom Motion Programs in Multimedia Display of Action-Oriented DVD Films
28. Reevaluating measures of disease progression in facioscapulohumeral muscular dystrophy
29. High frequency of gastrointestinal manifestations in myotonic dystrophy type 1 and type 2
30. A Facility for Simulating Room Acoustics, Employing a High Density Hemispherical Array of Loudspeakers
31. If you build a rare disease registry, will they enroll and will they use it? Methods and data from the National Registry of Myotonic Dystrophy (DM) and Facioscapulohumeral Muscular Dystrophy (FSHD)
32. Milestones of progression in myotonic dystrophy type 1 and type 2
33. Hypothesis: Neoplasms in Myotonic Dystrophy
34. Myotonic dystrophy health index: Correlations with clinical tests and patient function
35. SPINAL MUSCULAR ATROPHY FUNCTIONAL COMPOSITE SCORE: A FUNCTIONAL MEASURE IN SPINAL MUSCULAR ATROPHY
36. Diagnostic odyssey of patients with myotonic dystrophy
37. Health related quality of life in young, steroid-naïve boys with Duchenne muscular dystrophy
38. Correlates of tumor development in patients with myotonic dystrophy
39. MYOTONIC DYSTROPHY HEALTH INDEX: INITIAL EVALUATION OF A DISEASE-SPECIFIC OUTCOME MEASURE
40. Psychometric properties of the PEDI-CAT for children and youth with spinal muscular atrophy
41. Applying adaptive recognition of the learner’s vowel space to English pronunciation training of native speakers of Japanese
42. An expanded version of the Hammersmith Functional Motor Scale for SMA II and III patients
43. The effect of spin level and ball exit speed on forearm muscle activity in the tennis forehand stroke
44. Techniques for Sonifying Head Related Transfer Functions
45. Assessing Bulbar Function in Spinal Muscular Atrophy Using Patient-Reported Outcomes
46. A quantitative measure of handgrip myotonia in non-dystrophic myotonia
47. Laboratory Abnormalities in Patients With Myotonic Dystrophy Type 2
48. Open-Label Trial of Recombinant Human Insulin-like Growth Factor 1/Recombinant Human Insulin-like Growth Factor Binding Protein 3 in Myotonic Dystrophy Type 1
49. Mexiletine in Myotonic Dystrophy Type 1
50. Association of Plastin 3 Expression With Disease Severity in Spinal Muscular Atrophy Only in Postpubertal Females
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.